Semin Neurol 2018; 38(06): 640-643
DOI: 10.1055/s-0038-1673674
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Myofascial Pain

Jason L. Weller
1   Department of Neurology, Boston VA Healthcare System, Boston, Massachusetts
2   Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
,
Douglas Comeau
3   Division of Sports Medicine, Boston University, Boston, Massachusetts
4   Department of Family Medicine, Boston University School of Medicine, Boston, Massachusetts
5   Division of Sports Medicine, Boston College, Boston, Massachusetts
,
James A.D. Otis
2   Department of Neurology, Boston University School of Medicine, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
06 December 2018 (online)

Abstract

Myofascial pain syndromes arise from acute and chronic musculoskeletal pain and often have a referred neuropathic component. It affects more than three quarters of the world's population and is one of the most important and overlooked causes of disability. The origins of pain are thought to reside anywhere between the motor end plate and the fibrous outer covering of the muscle, with involvement of microvasculature and neurotransmitters at the cellular level. Diagnosis is made by clinical examination for the presence of myofascial trigger points, though some ancillary tests may provide supportive evidence. The mainstay of treatment is regular physical therapy with the goal of restoration of normal muscle laxity and range of motion. Adjunct therapies including pharmacologic and nonpharmacologic interventions provide varying degrees of benefit in refractory cases, and onabotulinum toxin A injection has the most evidence of efficacy for these patients. Here, we discuss the epidemiology, pathophysiology, and diagnostic and therapeutic options for the evaluation and treatment of myofascial pain syndrome.

 
  • References

  • 1 Fink R. Pain assessment: the cornerstone to optimal pain management. Proc (Bayl Univ Med Cent) 2000; 13: 236-239
  • 2 Chandola HC, Chakraborty A. Fibromyalgia and myofascial pain syndrome-a dilemma. Indian J Anaesth 2009; 53 (05) 575-581
  • 3 Couto C, de Souza IC, Torres IL, Fregni F, Caumo W. Paraspinal stimulation combined with trigger point needling and needle rotation for the treatment of myofascial pain: a randomized sham-controlled clinical trial. Clin J Pain 2014; 30 (03) 214-223
  • 4 Bruce E. Myofascial pain syndrome: early recognition and comprehensive management. AAOHN J 1995; 43 (09) 469-474
  • 5 Pal US, Kumar L, Mehta G. , et al. Trends in management of myofacial pain. Natl J Maxillofac Surg 2014; 5 (02) 109-116
  • 6 Desai MJ, Saini V, Saini S. Myofascial pain syndrome: a treatment review. Pain Ther 2013; 2 (01) 21-36
  • 7 Jafri MS. Mechanisms of myofascial pain. Int Sch Res Notices 2014; 2014: 523924
  • 8 Borg-Stein J, Simons DG. Focused review: myofascial pain. Arch Phys Med Rehabil 2002; 83 (03) (Suppl. 01) S40-S47 , S48–S49
  • 9 Stecco A, Gesi M, Stecco C, Stern R. Fascial components of the myofascial pain syndrome. Curr Pain Headache Rep 2013; 17 (08) 352
  • 10 Kietrys DM, Palombaro KM, Azzaretto E. , et al. Effectiveness of dry needling for upper-quarter myofascial pain: a systematic review and meta-analysis. J Orthop Sports Phys Ther 2013; 43 (09) 620-634
  • 11 Giamberardino MA, Affaitati G, Fabrizio A, Costantini R. Myofascial pain syndromes and their evaluation. Best Pract Res Clin Rheumatol 2011; 25 (02) 185-198
  • 12 Malanga GA, Cruz Colon EJ. Myofascial low back pain: a review. Phys Med Rehabil Clin N Am 2010; 21 (04) 711-724